Citius Oncology Inc.CTORNASDAQ
Loading
EV/EBITDA Over TimeContracting
Percentile Rank33
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-6.33
↑ 74% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-23.93
Historical baseline
PeriodValueYoY Change
2025-6.33-26.1%
2024-5.02+94.1%
2023-84.38-
20220.00-